4D Molecular Therapeutics, Inc. (FDMT) › Total Liabilities4D Molecular Therapeutics, Inc. (FDMT) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2019: $28.22M2020: $31.94M2021: $34.38M2022: $30.51M2023: $32.06M2024: $49.78M2025: $61.05M$61.05M2019Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$61.05M+22.6%2024$49.78M+55.3%2023$32.06M+5.1%2022$30.51M-11.3%2021$34.38M+7.6%2020$31.94M+13.2%2019$28.22M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share